Does BOTULINUM TOXIN TYPE A Cause Porphyria acute? 21 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Porphyria acute have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 0.6% of all adverse event reports for BOTULINUM TOXIN TYPE A.
21
Reports of Porphyria acute with BOTULINUM TOXIN TYPE A
0.6%
of all BOTULINUM TOXIN TYPE A reports
21
Deaths
21
Hospitalizations
How Dangerous Is Porphyria acute From BOTULINUM TOXIN TYPE A?
Of the 21 reports, 21 (100.0%) resulted in death, 21 (100.0%) required hospitalization, and 21 (100.0%) were considered life-threatening.
Is Porphyria acute Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Porphyria acute?
GIVOSIRAN (381)
RITUXIMAB (265)
DICLOFENAC (262)
LEFLUNOMIDE (249)
TOCILIZUMAB (243)
SECUKINUMAB (241)
METHOTREXATE (238)
ACETAMINOPHEN (237)
ADALIMUMAB (236)
PREDNISONE (227)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Porphyria acute Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE